{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Depression", "Natural medicinal plant", "Novel Drug Delivery System", "Novel drug delivery carriers", "Novel drug delivery pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37884969", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "27"}], "Language": ["eng"], "ELocationID": ["391", "10.1186/s12951-023-02159-9"], "Journal": {"ISSN": "1477-3155", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "27"}}, "Title": "Journal of nanobiotechnology", "ISOAbbreviation": "J Nanobiotechnology"}, "ArticleTitle": "Novel drug delivery strategies for antidepressant active ingredients from natural medicinal plants: the state of the art.", "Pagination": {"StartPage": "391", "MedlinePgn": "391"}, "Abstract": {"AbstractText": ["Depression is a severe mental disorder among public health issues. Researchers in the field of mental health and clinical psychiatrists have long been faced with difficulties in slow treatment cycles, high recurrence rates, and lagging efficacy. These obstacles have forced us to seek more advanced and effective treatments. Research has shown that novel drug delivery strategies for natural medicinal plants can effectively improve the utilization efficiency of the active molecules in these plants and therefore improve their efficacy. Currently, with the development of treatment technologies and the constant updating of novel drug delivery strategies, the addition of natural medicinal antidepressant therapy has given new significance to the study of depression treatment against the background of novel drug delivery systems. Based on this, this review comprehensively evaluates and analyses the research progress in novel drug delivery systems, including nanodrug delivery technology, in intervention research strategies for neurological diseases from the perspective of natural medicines for depression treatment. This provided a new theoretical foundation for the development and application of novel drug delivery strategies and drug delivery technologies in basic and clinical drug research fields."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, 250355, People's Republic of China."}], "LastName": "Yuan", "ForeName": "Shun", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, 250355, People's Republic of China."}], "LastName": "Ma", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, 250355, People's Republic of China."}, {"Identifier": [], "Affiliation": "Shandong Co-Innovation Center of Classic TCM Formula, Shandong University of Traditional Chinese Medicine, No 4655, University Road, Changqing District, Jinan, 250355, Shandong, China."}], "LastName": "Zhang", "ForeName": "Ya-Nan", "Initials": "YN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, 250355, People's Republic of China."}, {"Identifier": [], "Affiliation": "Shandong Co-Innovation Center of Classic TCM Formula, Shandong University of Traditional Chinese Medicine, No 4655, University Road, Changqing District, Jinan, 250355, Shandong, China."}], "LastName": "Wang", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China."}], "LastName": "Baloch", "ForeName": "Zulqarnain", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, 250355, People's Republic of China. make19880710@163.com."}, {"Identifier": [], "Affiliation": "Shandong Co-Innovation Center of Classic TCM Formula, Shandong University of Traditional Chinese Medicine, No 4655, University Road, Changqing District, Jinan, 250355, Shandong, China. make19880710@163.com."}], "LastName": "Ma", "ForeName": "Ke", "Initials": "K"}], "GrantList": [{"GrantID": "81903948", "Agency": "National Nature Science Foundation of China", "Country": ""}, {"GrantID": "2019-9-202", "Agency": "Shandong Province Universities' Development Plan for Youth Innovation Teams", "Country": ""}, {"GrantID": "2020GXRC012", "Agency": "The Jinan City University Institute Innovation Team Project", "Country": ""}, {"GrantID": "2023-143", "Agency": "special fund for high-level talent cultivation project of traditional Chinese medicine in Shandong Province", "Country": ""}, {"GrantID": "2023-761027", "Agency": "Shanghai Science and Technology Development Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Nanobiotechnology", "NlmUniqueID": "101152208", "ISSNLinking": "1477-3155"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Smith K. Mental health: a world of depression. Nature. 2014;515:180\u2013181. doi: 10.1038/515180a.", "ArticleIdList": ["10.1038/515180a", "25391942"]}, {"Citation": "Feng ST, Wang XL, Wang YT, Yuan YH, Li ZP, Chen NH, Wang ZZ, Zhang Y. Efficacy of Traditional chinese medicine combined with selective serotonin reuptake inhibitors on the treatment for Parkinson\u2019s disease with depression: a systematic review and meta-analysis. Am J Chin Med. 2021;49:627\u2013643. doi: 10.1142/S0192415X21500282.", "ArticleIdList": ["10.1142/S0192415X21500282", "33657988"]}, {"Citation": "Zhang Y, Wang ZZ, Sun HM, Li P, Li YF, Chen NH. Systematic review of traditional chinese medicine for depression in Parkinson's disease. Am J Chin Med. 2014;42:1035\u20131051. doi: 10.1142/S0192415X14500657.", "ArticleIdList": ["10.1142/S0192415X14500657", "25183301"]}, {"Citation": "Zhang G, Xiong N, Zhang Z, Liu L, Huang J, Yang J, Wu J, Lin Z, Wang T. Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis. PLoS ONE. 2015;10:e0118498. doi: 10.1371/journal.pone.0118498.", "ArticleIdList": ["10.1371/journal.pone.0118498", "PMC4355291", "25756963"]}, {"Citation": "Cheng G, Liu Y, Ma R, Cheng G, Guan Y, Chen X, Wu Z, Chen T. Anti-Parkinsonian therapy: strategies for crossing the blood-brain barrier and nano-biological effects of nanomaterials. Nanomicro Lett. 2022;14:105.", "ArticleIdList": ["PMC9012800", "35426525"]}, {"Citation": "Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6:268\u2013286. doi: 10.1016/j.apsb.2016.05.013.", "ArticleIdList": ["10.1016/j.apsb.2016.05.013", "PMC4951594", "27471668"]}, {"Citation": "Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7:a020412. doi: 10.1101/cshperspect.a020412.", "ArticleIdList": ["10.1101/cshperspect.a020412", "PMC4292164", "25561720"]}, {"Citation": "Reeve A, Simcox E, Turnbull D. Ageing and Parkinson's disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14:19\u201330. doi: 10.1016/j.arr.2014.01.004.", "ArticleIdList": ["10.1016/j.arr.2014.01.004", "PMC3989046", "24503004"]}, {"Citation": "Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, et al. Strategies to advance translational research into brain barriers. Lancet Neurol. 2008;7:84\u201396. doi: 10.1016/S1474-4422(07)70326-5.", "ArticleIdList": ["10.1016/S1474-4422(07)70326-5", "18093565"]}, {"Citation": "Nagpal K, Singh SK, Mishra DN. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opin Drug Deliv. 2013;10:927\u2013955. doi: 10.1517/17425247.2013.762354.", "ArticleIdList": ["10.1517/17425247.2013.762354", "23330786"]}, {"Citation": "Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv. 2003;3(90\u2013105):151.", "ArticleIdList": ["14993430"]}, {"Citation": "Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64:640\u2013665. doi: 10.1016/j.addr.2011.11.010.", "ArticleIdList": ["10.1016/j.addr.2011.11.010", "22154620"]}, {"Citation": "Takata F, Nakagawa S, Matsumoto J, Dohgu S. Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front Cell Neurosci. 2021;15:661838. doi: 10.3389/fncel.2021.661838.", "ArticleIdList": ["10.3389/fncel.2021.661838", "PMC8475767", "34588955"]}, {"Citation": "Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201. doi: 10.1016/j.neuron.2008.01.003.", "ArticleIdList": ["10.1016/j.neuron.2008.01.003", "18215617"]}, {"Citation": "Daneman R. The blood-brain barrier in health and disease. Ann Neurol. 2012;72:648\u2013672. doi: 10.1002/ana.23648.", "ArticleIdList": ["10.1002/ana.23648", "23280789"]}, {"Citation": "Profaci CP, Munji RN, Pulido RS, Daneman R. The blood-brain barrier in health and disease: important unanswered questions. J Exp Med. 2020;217:e20190062. doi: 10.1084/jem.20190062.", "ArticleIdList": ["10.1084/jem.20190062", "PMC7144528", "32211826"]}, {"Citation": "Tosi G, Duskey JT, Kreuter J. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin Drug Deliv. 2020;17:23\u201332. doi: 10.1080/17425247.2020.1698544.", "ArticleIdList": ["10.1080/17425247.2020.1698544", "31774000"]}, {"Citation": "Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, Tang L, Ma X, Zhang Y, Wang Y. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials. 2021;273:120784. doi: 10.1016/j.biomaterials.2021.120784.", "ArticleIdList": ["10.1016/j.biomaterials.2021.120784", "33848731"]}, {"Citation": "Mingzhao Z. Beyond the traditional route of administration. Foreign Sci Technol Trends. 2001;12:8\u20139."}, {"Citation": "Mc Gillicuddy A, Crean AM, Sahm LJ. Older adults with difficulty swallowing oral medicines: a systematic review of the literature. Eur J Clin Pharmacol. 2016;72:141\u2013151. doi: 10.1007/s00228-015-1979-8.", "ArticleIdList": ["10.1007/s00228-015-1979-8", "26573594"]}, {"Citation": "Kaur G, Arora M, Ravi Kumar MNV. Oral drug delivery technologies: a decade of developments. J Pharmacol Exp Ther. 2019;370:529\u2013543. doi: 10.1124/jpet.118.255828.", "ArticleIdList": ["10.1124/jpet.118.255828", "PMC6806634", "31010845"]}, {"Citation": "McConville JT. Current developments in oral drug administration. Drug Dev Ind Pharm. 2017;43:699. doi: 10.1080/03639045.2017.1290865.", "ArticleIdList": ["10.1080/03639045.2017.1290865", "28253737"]}, {"Citation": "\u00d6zt\u00fcrk AA, Arpagaus C. Nano Spray-Dried Drugs for Oral Administration: A Review. Chin J Tradit Chin Med. 2021;19:412\u2013441.", "ArticleIdList": ["34550790"]}, {"Citation": "Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021;5:951\u2013967. doi: 10.1038/s41551-021-00698-w.", "ArticleIdList": ["10.1038/s41551-021-00698-w", "33795852"]}, {"Citation": "Bae YH, Park K. Advanced drug delivery 2020 and beyond: Perspectives on the future. Adv Drug Deliv Rev. 2020;158:4\u201316. doi: 10.1016/j.addr.2020.06.018.", "ArticleIdList": ["10.1016/j.addr.2020.06.018", "PMC7736191", "32592727"]}, {"Citation": "Martinho N, Damg\u00e9 C, Reis CP. Recent advances in drug delivery systems. J Biomater Nanobiotechnology. 2011;2:510. doi: 10.4236/jbnb.2011.225062.", "ArticleIdList": ["10.4236/jbnb.2011.225062"]}, {"Citation": "Jain KK. Drug delivery systems. Totowa: Springer; 2008."}, {"Citation": "Zhuang W, Liu S-L, Xi S-Y, Feng Y-N, Wang K, Abduwali T, Liu P, Zhou X-J, Zhang L, Dong X-Z. Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: Efficacies and mechanisms. J Ethnopharmacol. 2023;307:116272. doi: 10.1016/j.jep.2023.116272.", "ArticleIdList": ["10.1016/j.jep.2023.116272", "36791924"]}, {"Citation": "Li Ruyue DG, Xinyi Y. Study on pharmacodynamics and pharmacokinetics of Hypericum perforatum combined with sertraline in depression model rats. Jiangsu Trad Chin Med. 2022;54:69\u201373."}, {"Citation": "Van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet. 1991; 21:110\u2013128.", "ArticleIdList": ["1884566"]}, {"Citation": "Shen Shi W, Song H. Regulatory effect and mechanism of magnesium baicalin on depression-like behavior and neuroinflammation induced by lipopolysaccharide in rats. China J Pharm. 2023;58:338\u2013346."}, {"Citation": "Zhao Zhiyu WW, Guo H. Effect of liquiritin on weight and behavior of depression model rats. Chin Mental Health J. 2006;12:787\u2013790."}, {"Citation": "Zou Yuchi CJ, Huang W. Effects of curcumin analogue L6H3 on monoamine neurotransmitter metabolites in striatum of Parkinson's disease rats. J Wenzhou Med Univ. 2019;49:625\u2013629."}, {"Citation": "Zhang T-T, Jiang J-G. Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opin Investig Drugs. 2012;21:1625\u20131642. doi: 10.1517/13543784.2012.713937.", "ArticleIdList": ["10.1517/13543784.2012.713937", "22862558"]}, {"Citation": "Liu X, Shi D, Zhou S, Liu H, Liu H, Yao X. Molecular dynamics simulations and novel drug discovery. Expert Opin Drug Discov. 2018;13:23\u201337. doi: 10.1080/17460441.2018.1403419.", "ArticleIdList": ["10.1080/17460441.2018.1403419", "29139324"]}, {"Citation": "Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci. 1996;93:14164\u201314169. doi: 10.1073/pnas.93.24.14164.", "ArticleIdList": ["10.1073/pnas.93.24.14164", "PMC19511", "8943078"]}, {"Citation": "Wang A-A, Li L, Li Y, Miao L, Pan Y-H, Liu J-X. Research progress on Chinese medicinal material-derived active polypeptides against ischemic cardiovascular and cerebrovascular diseases. Zhongguo Zhong Yao Za Zhi. 2021;46:5576\u20135584.", "ArticleIdList": ["34951209"]}, {"Citation": "Shi Zhongkai HX, You Y. Experimental study on anti-tumor activity of ethanol extract from roots of Linqian on S-180 tumor-bearing mice. Journal of Chengdu University of Traditional Chinese Medicine. 2011;34:41\u201343."}, {"Citation": "Baolan S. Research progress of anti-liver injury traditional Chinese medicine and its mechanism of action. Everybody's Health (Academic Edition) 2014;8:49."}, {"Citation": "Shen Shi W GX, Song Hongru. Regulatory effect and mechanism of magnesium baicalin on depression-like behavior and neuroinflammation induced by lipopolysaccharide in rats. China Journal of Pharmacy. 2023;58:338\u2013346."}, {"Citation": "Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M. Strategy for effective brain drug delivery. Eur J Pharm Sci. 2010;40:385\u2013403. doi: 10.1016/j.ejps.2010.05.003.", "ArticleIdList": ["10.1016/j.ejps.2010.05.003", "20497904"]}, {"Citation": "Ma G. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications. J Control Release. 2014;193:324\u2013340. doi: 10.1016/j.jconrel.2014.09.003.", "ArticleIdList": ["10.1016/j.jconrel.2014.09.003", "25218676"]}, {"Citation": "Li C, Wang J, Wang Y, Gao H, Wei G, Huang Y, Yu H, Gan Y, Wang Y, Mei L. Recent progress in drug delivery. Acta Pharm Sin B. 2019;9:1145\u20131162. doi: 10.1016/j.apsb.2019.08.003.", "ArticleIdList": ["10.1016/j.apsb.2019.08.003", "PMC6900554", "31867161"]}, {"Citation": "Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149. doi: 10.1146/annurev-chembioeng-073009-100847.", "ArticleIdList": ["10.1146/annurev-chembioeng-073009-100847", "PMC3438887", "22432577"]}, {"Citation": "Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug delivery strategies for precision medicines. Nat Rev Mater. 2021;6:351\u2013370. doi: 10.1038/s41578-020-00269-6.", "ArticleIdList": ["10.1038/s41578-020-00269-6", "PMC8691416", "34950512"]}, {"Citation": "Cai SS, Li T, Akinade T, Zhu Y, Leong KW. Drug delivery carriers with therapeutic functions. Adv Drug Deliv Rev. 2021;176:113884. doi: 10.1016/j.addr.2021.113884.", "ArticleIdList": ["10.1016/j.addr.2021.113884", "PMC8440421", "34302897"]}, {"Citation": "He Ying FF, Yan Hongli. Momordica charantia MAP30 promotes autophagy and apoptosis of multiple myeloma cells through AKT/mTOR pathway. chinese journal of cancer biotherapy. 2019; 26:299\u2013305."}, {"Citation": "Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E. Targeted drug delivery\u2014from magic bullet to nanomedicine: principles, challenges, and future perspectives. J Multidiscip Healthc. 2021;14:1711\u20131724. doi: 10.2147/JMDH.S313968.", "ArticleIdList": ["10.2147/JMDH.S313968", "PMC8275483", "34267523"]}, {"Citation": "Hakim LK, Yazdanian M, Alam M, Abbasi K, Tebyaniyan H, Tahmasebi E, Khayatan D, Seifalian A, Ranjbar R, Yazdanian A. Biocompatible and biomaterials application in drug delivery system in oral cavity. Evid Based Complement Alternat Med. 2021;2021:1. doi: 10.1155/2021/9011226.", "ArticleIdList": ["10.1155/2021/9011226", "PMC8605911", "34812267"]}, {"Citation": "Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021;12:618411. doi: 10.3389/fphar.2021.618411.", "ArticleIdList": ["10.3389/fphar.2021.618411", "PMC7933596", "33679401"]}, {"Citation": "Haywood A, Glass BD. Pharmaceutical excipients\u2013where do we begin? Aust Prescr. 2011;34:112. doi: 10.18773/austprescr.2011.060.", "ArticleIdList": ["10.18773/austprescr.2011.060"]}, {"Citation": "Am Ende MT. Chemical engineering in the pharmaceutical industry: active pharmaceutical ingredients. Hoboken: Wiley; 2019."}, {"Citation": "Zompra AA, Galanis AS, Werbitzky O, Albericio F. Manufacturing peptides as active pharmaceutical ingredients. Future Med Chem. 2009;1:361\u2013377. doi: 10.4155/fmc.09.23.", "ArticleIdList": ["10.4155/fmc.09.23", "21425973"]}, {"Citation": "Park H, Otte A, Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release. 2022;342:53\u201365. doi: 10.1016/j.jconrel.2021.12.030.", "ArticleIdList": ["10.1016/j.jconrel.2021.12.030", "PMC8840987", "34971694"]}, {"Citation": "Barkat MA, Rizwanullah M, Pottoo FH, Beg S, Akhter S, Ahmad FJ. Therapeutic nanoemulsion: concept to delivery. Curr Pharm Des. 2020;26:1145\u20131166. doi: 10.2174/1381612826666200317140600.", "ArticleIdList": ["10.2174/1381612826666200317140600", "32183664"]}, {"Citation": "Lu XY, Wu DC, Li ZJ, Chen GQ. Polymer nanoparticles. Prog Mol Biol Transl Sci. 2011;104:299\u2013323. doi: 10.1016/B978-0-12-416020-0.00007-3.", "ArticleIdList": ["10.1016/B978-0-12-416020-0.00007-3", "22093222"]}, {"Citation": "Elvira C, Gallardo A, Roman JS, Cifuentes A. Covalent polymer-drug conjugates. Molecules. 2005;10:114\u2013125. doi: 10.3390/10010114.", "ArticleIdList": ["10.3390/10010114", "PMC6147706", "18007281"]}, {"Citation": "Dang W, Colvin OM, Brem H, Saltzman WM. Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix. Cancer Res. 1994;54:1729\u20131735.", "ArticleIdList": ["7511049"]}, {"Citation": "Guan Qingxia HX, Li W. Research progress of liver-targeted nano-drug delivery system loaded with traditional Chinese medicine. China Pharm. 2015;26:1002\u20131005."}, {"Citation": "Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Frontiers in pharmacology.2021;12:618411\u2013618417.", "ArticleIdList": ["PMC7933596", "33679401"]}, {"Citation": "Duan Xiaoying JQ, Liu L. Preparation of Matrine Nanoparticles and Modified Products of Wheat Germ Lectin. Chin Patent Med. 2017;39:55\u201360."}, {"Citation": "Harwansh RK, Deshmukh R, Rahman MA. Nanoemulsion: Promising nanocarrier system for delivery of herbal bioactives. J Drug Deliv Sci Technol. 2019;51:224\u2013233. doi: 10.1016/j.jddst.2019.03.006.", "ArticleIdList": ["10.1016/j.jddst.2019.03.006"]}, {"Citation": "Zhang Yanfang GY, Wu R. Research progress of Chinese medicine extract nanoemulsion and its pharmacokinetics. China J Chin Med Inform. 2020;27:141\u2013144."}, {"Citation": "Kotta S, Aldawsari HM, Badr-Eldin SM, Alhakamy NA, Md S. Coconut oil-based resveratrol nanoemulsion: optimization using response surface methodology, stability assessment and pharmacokinetic evaluation. Food Chem. 2021;357:129721. doi: 10.1016/j.foodchem.2021.129721.", "ArticleIdList": ["10.1016/j.foodchem.2021.129721", "33866243"]}, {"Citation": "Mohamed S, Parayath NN, Taurin S, Greish K. Polymeric nano-micelles: versatile platform for targeted delivery in cancer. Ther Deliv. 2014;5:1101\u20131121. doi: 10.4155/tde.14.69.", "ArticleIdList": ["10.4155/tde.14.69", "25418269"]}, {"Citation": "Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv Drug Deliv Rev. 2020;156:80\u2013118. doi: 10.1016/j.addr.2020.09.009.", "ArticleIdList": ["10.1016/j.addr.2020.09.009", "PMC8173698", "32980449"]}, {"Citation": "Gill KK, Kaddoumi A, Nazzal S. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. Eur J Pharm Sci. 2012;46:64\u201371. doi: 10.1016/j.ejps.2012.02.010.", "ArticleIdList": ["10.1016/j.ejps.2012.02.010", "22369858"]}, {"Citation": "Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Liposomes: advancements and innovation in the manufacturing process. Adv Drug Deliv Rev. 2020;154\u2013155:102\u2013122. doi: 10.1016/j.addr.2020.07.002.", "ArticleIdList": ["10.1016/j.addr.2020.07.002", "32650041"]}, {"Citation": "Almeida B, Nag OK, Rogers KE, Delehanty JB. Recent progress in bioconjugation strategies for liposome-mediated drug delivery. Molecules. 2020;25:5672. doi: 10.3390/molecules25235672.", "ArticleIdList": ["10.3390/molecules25235672", "PMC7730700", "33271886"]}, {"Citation": "Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571. doi: 10.1016/j.ijpharm.2021.120571.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120571", "33812967"]}, {"Citation": "Yan Dekang ZX, Wang Y. Formulation optimization of mannose modified curcumin/ginsenoside Rb1 liposomes and evaluation of brain targeting in vitro. China Pharm. 2022;25:11\u201317."}, {"Citation": "Walther R, Rautio J, Zelikin AN. Prodrugs in medicinal chemistry and enzyme prodrug therapies. Adv Drug Deliv Rev. 2017;118:65\u201377. doi: 10.1016/j.addr.2017.06.013.", "ArticleIdList": ["10.1016/j.addr.2017.06.013", "28676386"]}, {"Citation": "Kang T, Miao Z, Liu S, Ke B. Prodrug strategies in the CNS drugs: small modification makes big improvements. Curr Top Med Chem. 2021;21:2157\u20132169. doi: 10.2174/1568026621666210727163827.", "ArticleIdList": ["10.2174/1568026621666210727163827", "34315372"]}, {"Citation": "Chen KJ, Plaunt AJ, Leifer FG, Kang JY, Cipolla D. Recent advances in prodrug-based nanoparticle therapeutics. Eur J Pharm Biopharm. 2021;165:219\u2013243. doi: 10.1016/j.ejpb.2021.04.025.", "ArticleIdList": ["10.1016/j.ejpb.2021.04.025", "33979661"]}, {"Citation": "Abet V, Filace F, Recio J, Alvarez-Builla J, Burgos C. Prodrug approach: an overview of recent cases. Eur J Med Chem. 2017;127:810\u2013827. doi: 10.1016/j.ejmech.2016.10.061.", "ArticleIdList": ["10.1016/j.ejmech.2016.10.061", "27823878"]}, {"Citation": "Mehellou Y, Rattan HS, Balzarini J. The ProTide prodrug technology: from the concept to the clinic. J Med Chem. 2018;61:2211\u20132226. doi: 10.1021/acs.jmedchem.7b00734.", "ArticleIdList": ["10.1021/acs.jmedchem.7b00734", "PMC7075648", "28792763"]}, {"Citation": "Jana S, Mandlekar S, Marathe P. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists. Curr Med Chem. 2010;17:3874\u20133908. doi: 10.2174/092986710793205426.", "ArticleIdList": ["10.2174/092986710793205426", "20858214"]}, {"Citation": "Bodor N, Kaminski JJ. Prodrugs and site-specific chemical delivery systems. Ann Rep Med Chem. 1987;22:303\u2013313."}, {"Citation": "Chen Juan PL, Yang Xiaoyi. Analysis of global research and development situation of virus vector vaccine products. China Pharmaceutical. 2022; 31:24\u201329."}, {"Citation": "He F, Wen N, Xiao D, Yan J, Xiong H, Cai S, Liu Z, Liu Y. Aptamer-based targeted drug delivery systems: current potential and challenges. Curr Med Chem. 2020;27:2189\u20132219. doi: 10.2174/0929867325666181008142831.", "ArticleIdList": ["10.2174/0929867325666181008142831", "30295183"]}, {"Citation": "Liu P, Jiang C. Brain-targeting drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14:e1818. doi: 10.1002/wnan.1818.", "ArticleIdList": ["10.1002/wnan.1818", "35596258"]}, {"Citation": "Shah V, Kochar P. Brain cancer: implication to disease, therapeutic strategies and tumor targeted drug delivery approaches. Recent Pat Anticancer Drug Discov. 2018;13:70\u201385. doi: 10.2174/1574892812666171129142023.", "ArticleIdList": ["10.2174/1574892812666171129142023", "29189177"]}, {"Citation": "Morachis JM, Mahmoud EA, Almutairi A. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev. 2012;64:505\u2013519. doi: 10.1124/pr.111.005363.", "ArticleIdList": ["10.1124/pr.111.005363", "PMC3400833", "22544864"]}, {"Citation": "Tian B, Hua S, Tian Y, Liu J. Chemical and physical chitosan hydrogels as prospective carriers for drug delivery: a review. J Mater Chem B. 2020;8:10050\u201310064. doi: 10.1039/D0TB01869D.", "ArticleIdList": ["10.1039/D0TB01869D", "33073280"]}, {"Citation": "Haiyan H. Research progress of magnetic targeting in physicochemical targeting preparations. Guangzhou Chem Ind. 2015;43:26\u201328."}, {"Citation": "Polyak B, Friedman G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin Drug Deliv. 2009;6:53\u201370. doi: 10.1517/17425240802662795.", "ArticleIdList": ["10.1517/17425240802662795", "19236208"]}, {"Citation": "Bietenbeck M, Florian A, Faber C, Sechtem U, Yilmaz A. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now? Int J Nanomedicine. 2016;11:3191\u20133203. doi: 10.2147/IJN.S110542.", "ArticleIdList": ["10.2147/IJN.S110542", "PMC4957681", "27486321"]}, {"Citation": "Yan Runmin LC, Zhao M. Experimental study on distribution of magnetic paclitaxel-ferroferric oxide-drug-loaded liposome complex particles in brain. Biomed Eng Clin Med. 2011;15:103\u2013106."}, {"Citation": "Peng N, Yu H, Yu W, Yang M, Chen H, Zou T, Deng K, Huang S, Liu Y. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer. Acta Biomater. 2020;105:223\u2013238. doi: 10.1016/j.actbio.2020.01.005.", "ArticleIdList": ["10.1016/j.actbio.2020.01.005", "31926335"]}, {"Citation": "Chen Conghui LM. Anti-tumor study of targeting and pH-sensitive lipoprotein-like nano-carriers carrying paclitaxel in vivo. China J Trad Chin Med. 2019;44:2072\u20132077."}, {"Citation": "Shirley JL, de Jong YP, Terhorst C, Herzog RW. Immune responses to viral gene therapy vectors. Mol Ther. 2020;28:709\u2013722. doi: 10.1016/j.ymthe.2020.01.001.", "ArticleIdList": ["10.1016/j.ymthe.2020.01.001", "PMC7054714", "31968213"]}, {"Citation": "Anderson WF. Prospects for human gene therapy. Science. 1984;226:401\u2013409. doi: 10.1126/science.6093246.", "ArticleIdList": ["10.1126/science.6093246", "6093246"]}, {"Citation": "Milone MC, O'Doherty U. Clinical use of lentiviral vectors. Leukemia. 2018;32:1529\u20131541. doi: 10.1038/s41375-018-0106-0.", "ArticleIdList": ["10.1038/s41375-018-0106-0", "PMC6035154", "29654266"]}, {"Citation": "Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther. 1994;1:51\u201364.", "ArticleIdList": ["7621239"]}, {"Citation": "Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346\u2013358. doi: 10.1038/nrg1066.", "ArticleIdList": ["10.1038/nrg1066", "12728277"]}, {"Citation": "Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Mu\u00f1oz Navarro SR, et al. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial. Lancet. 2022;399:237\u2013248. doi: 10.1016/S0140-6736(21)02753-7.", "ArticleIdList": ["10.1016/S0140-6736(21)02753-7", "PMC8700283", "34953526"]}, {"Citation": "Zhang YH, Wang Y, Yusufali AH, Ashby F, Zhang D, Yin ZF, Aslanidi GV, Srivastava A, Ling CQ, Ling C. Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. J Integr Med. 2014;12:483\u2013494. doi: 10.1016/S2095-4964(14)60057-1.", "ArticleIdList": ["10.1016/S2095-4964(14)60057-1", "25412666"]}, {"Citation": "Raposo G, Stahl PD. Extracellular vesicles: a new communication paradigm? Nat Rev Mol Cell Biol. 2019;20:509\u2013510. doi: 10.1038/s41580-019-0158-7.", "ArticleIdList": ["10.1038/s41580-019-0158-7", "31324871"]}, {"Citation": "S\u00f6llner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993;362:318\u2013324. doi: 10.1038/362318a0.", "ArticleIdList": ["10.1038/362318a0", "8455717"]}, {"Citation": "Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332\u2013343. doi: 10.1016/j.addr.2020.04.004.", "ArticleIdList": ["10.1016/j.addr.2020.04.004", "32305351"]}, {"Citation": "Zhao L, Hu C, Han F, Wang J, Chen J. Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury. J Cell Mol Med. 2020;24:4882\u20134891. doi: 10.1111/jcmm.15184.", "ArticleIdList": ["10.1111/jcmm.15184", "PMC7205784", "32281261"]}, {"Citation": "de Castilla PEM, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang J-W. Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies. Adv Drug Deliv Rev. 2021;175:113801. doi: 10.1016/j.addr.2021.05.011.", "ArticleIdList": ["10.1016/j.addr.2021.05.011", "34015418"]}, {"Citation": "Zhu Q, Ling X, Yang Y, Zhang J, Li Q, Niu X, Hu G, Chen B, Li H, Wang Y, Deng Z. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy. Adv Sci (Weinh) 2019;6:1801899. doi: 10.1002/advs.201801899.", "ArticleIdList": ["10.1002/advs.201801899", "PMC6425428", "30937268"]}, {"Citation": "Villa F, Quarto R, Tasso R. Extracellular vesicles as natural, safe and efficient drug delivery systems. Pharmaceutics. 2019;11:557. doi: 10.3390/pharmaceutics11110557.", "ArticleIdList": ["10.3390/pharmaceutics11110557", "PMC6920944", "31661862"]}, {"Citation": "Zou J, Shi M, Liu X, Jin C, Xing X, Qiu L, Tan W. Aptamer-functionalized exosomes: elucidating the cellular uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem. 2019;91:2425\u20132430. doi: 10.1021/acs.analchem.8b05204.", "ArticleIdList": ["10.1021/acs.analchem.8b05204", "PMC6662586", "30620179"]}, {"Citation": "Xi X-M, Xia S-J, Lu R. Drug loading techniques for exosome-based drug delivery systems. Die Pharm. 2021;76:61\u201367.", "ArticleIdList": ["33714281"]}, {"Citation": "Ajazuddin S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81:680\u2013689. doi: 10.1016/j.fitote.2010.05.001.", "ArticleIdList": ["10.1016/j.fitote.2010.05.001", "20471457"]}, {"Citation": "Thwala LN, Pr\u00e9at V, Csaba NS. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes. Expert Opin Drug Deliv. 2017;14:23\u201336. doi: 10.1080/17425247.2016.1206074.", "ArticleIdList": ["10.1080/17425247.2016.1206074", "27351299"]}, {"Citation": "Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol Today. 2000;3:318\u2013326. doi: 10.1016/S1461-5347(00)00295-9.", "ArticleIdList": ["10.1016/S1461-5347(00)00295-9", "10996573"]}, {"Citation": "Mavuso S, Marimuthu T, Choonara YE, Kumar P, du Toit LC, Pillay V. A review of polymeric colloidal nanogels in transdermal drug delivery. Curr Pharm Des. 2015;21:2801\u20132813. doi: 10.2174/1381612821666150428142920.", "ArticleIdList": ["10.2174/1381612821666150428142920", "25925117"]}, {"Citation": "Lan Y, Wang J, Li H, Zhang Y, Chen Y, Zhao B, Wu Q. Effect of menthone and related compounds on skin permeation of drugs with different lipophilicity and molecular organization of stratum corneum lipids. Pharm Dev Technol. 2016;21:389\u2013398.", "ArticleIdList": ["25684238"]}, {"Citation": "Balfour DJ, Fagerstr\u00f6m KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther. 1996;72:51\u201381. doi: 10.1016/S0163-7258(96)00099-X.", "ArticleIdList": ["10.1016/S0163-7258(96)00099-X", "8981571"]}, {"Citation": "Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001;49:258\u2013267. doi: 10.1016/S0006-3223(00)01094-5.", "ArticleIdList": ["10.1016/S0006-3223(00)01094-5", "11230877"]}, {"Citation": "Singh N, Pillay V, Choonara YE. Advances in the treatment of Parkinson's disease. Prog Neurobiol. 2007;81:29\u201344. doi: 10.1016/j.pneurobio.2006.11.009.", "ArticleIdList": ["10.1016/j.pneurobio.2006.11.009", "17258379"]}, {"Citation": "Shen Chengying SB, Xu P. Preparation of Ganoderma lucidum triterpenoid nanosuspension gel and its transdermal study in vitro. Chinese Herb Med. 2014;45:2770\u20132775."}, {"Citation": "Siegel SJ, Winey KI, Gur RE, Lenox RH, Bilker WB, Ikeda D, Gandhi N, Zhang WX. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology. 2002;26:817\u2013823. doi: 10.1016/S0893-133X(01)00426-2.", "ArticleIdList": ["10.1016/S0893-133X(01)00426-2", "12007752"]}, {"Citation": "Rabin C, Liang Y, Ehrlichman RS, Budhian A, Metzger KL, Majewski-Tiedeken C, Winey KI, Siegel SJ. In vitro and in vivo demonstration of risperidone implants in mice. Schizophr Res. 2008;98:66\u201378. doi: 10.1016/j.schres.2007.08.003.", "ArticleIdList": ["10.1016/j.schres.2007.08.003", "PMC2561216", "17765477"]}, {"Citation": "Wang Z, Xiong G, Tsang WC, Sch\u00e4tzlein AG, Uchegbu IF. Nose-to-brain delivery. J Pharmacol Exp Ther. 2019;370:593\u2013601. doi: 10.1124/jpet.119.258152.", "ArticleIdList": ["10.1124/jpet.119.258152", "31126978"]}, {"Citation": "Lobaina Mato Y. Nasal route for vaccine and drug delivery: features and current opportunities. Int J Pharm. 2019;572:118813. doi: 10.1016/j.ijpharm.2019.118813.", "ArticleIdList": ["10.1016/j.ijpharm.2019.118813", "31678521"]}, {"Citation": "Kashyap K, Shukla R. Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges. Curr Drug Deliv. 2019;16:887\u2013901. doi: 10.2174/1567201816666191029122740.", "ArticleIdList": ["10.2174/1567201816666191029122740", "31660815"]}, {"Citation": "Dongyuan L. Theory of qi alternation in five organs. Bull Trad Chin Med. 2016;15:40."}, {"Citation": "Hou H, Li Y, Xu Z, Yu Z, Peng B, Wang C, Liu W, Li W, Ye Z, Zhang G. Applications and research progress of traditional Chinese medicine delivered via nasal administration. Biomed Pharmacother. 2023;157:113933. doi: 10.1016/j.biopha.2022.113933.", "ArticleIdList": ["10.1016/j.biopha.2022.113933", "36399826"]}, {"Citation": "Yang CX, Xu XH, Dong Y. Advances in the research on targeted preparations of traditional Chinese medicine and natural drugs. Zhongguo Zhong Yao Za Zhi. 2003;28:696\u2013700.", "ArticleIdList": ["15015344"]}, {"Citation": "Ju Aichun GS, Yang X. Effects of nasal administration of salvianolic acid B on learning and memory ability and nerve regeneration in rats with cerebral ischemia injury. Chin Herbal Med. 2017;48:2481\u20132485."}, {"Citation": "Sun Yaping ZY, Bai N. Effect of short-term nasal administration of genistein on alleviating neuronal damage after cerebral infarction in rats. Chin J Coal Ind Med. 2018;21:310\u2013315."}, {"Citation": "Guo Q, Li P, Wang Z, Cheng Y, Wu H, Yang B, Du S, Lu Y. Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;969:264\u2013271. doi: 10.1016/j.jchromb.2014.08.034.", "ArticleIdList": ["10.1016/j.jchromb.2014.08.034", "25203723"]}, {"Citation": "Dong Y, Shi J-R. Biological research evaluating the Chinese medical theory of the association of the kidney with the ears. Zhong Xi Yi Jie He Xue Bao. 2012;10:128\u2013134. doi: 10.3736/jcim20120202.", "ArticleIdList": ["10.3736/jcim20120202", "22313879"]}, {"Citation": "Zhu Q, Ling X, Yang Y, Zhang J, Li Q, Niu X, Hu G, Chen B, Li H, Wang Y, Deng Z. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy. Adv Sci (Weinh). 2019; 6:1809\u20131899.", "ArticleIdList": ["PMC6425428", "30937268"]}, {"Citation": "Villa F, Quarto R, Tasso R. Extracellular vesicles as natural, safe and efficient drug delivery systems. Pharmaceutics. 2019; 11:557\u2013561.", "ArticleIdList": ["PMC6920944", "31661862"]}, {"Citation": "An Xiaogang CD. Research progress of nano-particle drug delivery system in inner ear targeted drug delivery. Chin J Otol. 2020;18:409\u2013413."}, {"Citation": "Jiang W-Y. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci. 2005;26:558\u2013563. doi: 10.1016/j.tips.2005.09.006.", "ArticleIdList": ["10.1016/j.tips.2005.09.006", "16185775"]}, {"Citation": "Liu H, Hao J, Li KS. Current strategies for drug delivery to the inner ear. Acta Pharm Sin B. 2013;3:86\u201396. doi: 10.1016/j.apsb.2013.02.003.", "ArticleIdList": ["10.1016/j.apsb.2013.02.003"]}, {"Citation": "Qiu K, Mao M, Deng D, Jiang C, Li L, Zheng Y, Ren J, Zhao Y. Is postauricular injection a systemic or a topical route for inner ear drug delivery? Hear Res. 2022;422:108570. doi: 10.1016/j.heares.2022.108570.", "ArticleIdList": ["10.1016/j.heares.2022.108570", "35863163"]}, {"Citation": "Lee S, Dondzillo A, Gubbels SP, Raphael Y. Practical aspects of inner ear gene delivery for research and clinical applications. Hear Res. 2020;394:107934. doi: 10.1016/j.heares.2020.107934.", "ArticleIdList": ["10.1016/j.heares.2020.107934", "PMC7415623", "32204962"]}, {"Citation": "Xue Yaqi WZ, Liang Peiyi. Progress in molecular pharmaceutics of transdermal preparations of traditional Chinese medicine. Journal of Nanjing University of Traditional Chinese Medicine. 2022; 38:983\u2013989."}, {"Citation": "Pferschy-Wenzig E-M, Bauer R. The relevance of pharmacognosy in pharmacological research on herbal medicinal products. Epilepsy Behav. 2015;52:344\u2013362. doi: 10.1016/j.yebeh.2015.05.037.", "ArticleIdList": ["10.1016/j.yebeh.2015.05.037", "26169932"]}, {"Citation": "Jingjing W, Rongjuan G, Guojing F, Xiao Liang ZX, Min J, Zixiu Z, Wanqing D, Weiwei J, Linjuan S, Hongmei L. Registration of intervention trials of traditional Chinese medicine for four neurological diseases on Chinese clinical trial registry and ClinicalTrials.gov: a narrative review. J Trad Chin Med. 2022;42:148.", "ArticleIdList": ["PMC10164634", "35294135"]}, {"Citation": "Liu Y, Feng N. Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM) Adv Coll Interface Sci. 2015;221:60\u201376. doi: 10.1016/j.cis.2015.04.006.", "ArticleIdList": ["10.1016/j.cis.2015.04.006", "25999266"]}, {"Citation": "Verma H, Prasad SB, Yashwant SH. Herbal drug delivery system: a modern era prospective. Int J Current Pharma Rev Res. 2013;4:88\u2013101."}, {"Citation": "Dement'eva OV, Naumova KA, Zhigletsova SK, Klykova MV, Somov AN, Dunaytsev IA, Senchikhin IN, Volkov VV, Rudoy VM. Drug-templated mesoporous silica nanocontainers with extra high payload and controlled release rate. Colloids Surf B Biointerfaces. 2020;185:110577. doi: 10.1016/j.colsurfb.2019.110577.", "ArticleIdList": ["10.1016/j.colsurfb.2019.110577", "31675641"]}, {"Citation": "Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018;132:104\u2013138. doi: 10.1016/j.addr.2018.07.002.", "ArticleIdList": ["10.1016/j.addr.2018.07.002", "30415656"]}, {"Citation": "Yang D, Lee JS, Choi CK, Lee HP, Cho SW, Ryu W. Microchannel system for rate-controlled, sequential, and pH-responsive drug delivery. Acta Biomater. 2018;68:249\u2013260. doi: 10.1016/j.actbio.2017.12.013.", "ArticleIdList": ["10.1016/j.actbio.2017.12.013", "29269333"]}, {"Citation": "Severino P, da Silva CF, Andrade LN, de Lima OD, Campos J, Souto EB. Alginate nanoparticles for drug delivery and targeting. Curr Pharm Des. 2019;25:1312\u20131334. doi: 10.2174/1381612825666190425163424.", "ArticleIdList": ["10.2174/1381612825666190425163424", "31465282"]}, {"Citation": "Torchilin VP. Drug targeting. Eur J Pharm Sci. 2000;11(Suppl 2):S81\u201391. doi: 10.1016/S0928-0987(00)00166-4.", "ArticleIdList": ["10.1016/S0928-0987(00)00166-4", "11033430"]}, {"Citation": "Jain K. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegener Dis. 2007;4:287\u2013291. doi: 10.1159/000101884.", "ArticleIdList": ["10.1159/000101884", "17627131"]}, {"Citation": "Ipar VS, Dsouza A, Devarajan PV. Enhancing curcumin oral bioavailability through nanoformulations. Eur J Drug Metab Pharmacokinet. 2019;44:459\u2013480. doi: 10.1007/s13318-019-00545-z.", "ArticleIdList": ["10.1007/s13318-019-00545-z", "30771095"]}, {"Citation": "Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454\u2013477. doi: 10.1016/j.addr.2007.04.011.", "ArticleIdList": ["10.1016/j.addr.2007.04.011", "17570559"]}, {"Citation": "Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75:1\u201318. doi: 10.1016/j.colsurfb.2009.09.001.", "ArticleIdList": ["10.1016/j.colsurfb.2009.09.001", "19782542"]}, {"Citation": "Silva GA. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci. 2008;9:1\u20134. doi: 10.1186/1471-2202-9-S3-S4.", "ArticleIdList": ["10.1186/1471-2202-9-S3-S4", "PMC2604882", "19091001"]}, {"Citation": "Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019;4:e10143. doi: 10.1002/btm2.10143.", "ArticleIdList": ["10.1002/btm2.10143", "PMC6764803", "31572799"]}, {"Citation": "Havel H, Finch G, Strode P, Wolfgang M, Zale S, Bobe I, Youssoufian H, Peterson M, Liu M. Nanomedicines: from bench to bedside and beyond. AAPS J. 2016;18:1373\u20131378. doi: 10.1208/s12248-016-9961-7.", "ArticleIdList": ["10.1208/s12248-016-9961-7", "27480318"]}, {"Citation": "Silva GA. Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system. Ann NY Acad Sci. 2010;1199:221\u2013230. doi: 10.1111/j.1749-6632.2009.05361.x.", "ArticleIdList": ["10.1111/j.1749-6632.2009.05361.x", "20633128"]}, {"Citation": "Huo Liang PY, Liu X. Research progress of intestinal flora on metabolism of effective components of traditional Chinese medicine. Chin J Trad Chin Med. 2022;37:1605\u20131608."}, {"Citation": "Zhang Qi JY, Zheng HC, Zhao CB. Research progress on the interaction between metabolism of effective components of traditional Chinese medicine and intestinal flora. Northw Pharm J. 2022;37:186\u2013188."}, {"Citation": "Yuting J. Research progress of traditional Chinese medicine in regulating intestinal flora changes of colorectal cancer. Clin Res Trad Chin Med. 2021;13:136\u2013138."}, {"Citation": "Ke Qunhua PJ, Wang S. Research progress on traditional Chinese medicine and intestinal flora and its metabolism. J Trad Chin Vet Med. 2022;41:35\u201340."}, {"Citation": "Huang L, Zheng J, Sun G, Yang H, Sun X, Yao X, Lin A, Liu H. 5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. Cell Mol Life Sci. 2022;79:460. doi: 10.1007/s00018-022-04471-3.", "ArticleIdList": ["10.1007/s00018-022-04471-3", "35913641"]}, {"Citation": "Bi Huichang YM. Intestinal flora and drug metabolism. Pharm Prog. 2020;44:81\u201382."}, {"Citation": "Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186\u2013194. doi: 10.1016/j.bbi.2015.03.016.", "ArticleIdList": ["10.1016/j.bbi.2015.03.016", "25882912"]}, {"Citation": "Dong Y, Shi J-R. Biological research evaluating the Chinese medical theory of the association of the kidney with the ears. Zhong xi yi jie he xue bao= Journal of Chinese Integrative Medicine. 2012; 10:128\u2013134.", "ArticleIdList": ["22313879"]}, {"Citation": "Xu Yan LD, Ning T. Effects of Poria cocos on behavior and fecal flora in rats with mild and chronic unpredictable stress. China Pharmacovigil. 2021;18:748\u2013752."}, {"Citation": "Cai Saibo ZH, Xin X. Effect of taking Bupleurum chinense DC. on intestinal flora diversity in depressed mice. China J Trad Chin Med. 2021;46:4222\u20134229."}, {"Citation": "Song Ruiwen ZL, Wang S. Analysis of the effect of Jiawei Wendan Decoction on intestinal flora of depression model rats based on 16S rDNA high-throughput sequencing technique. J Trad Chin Med. 2021;48:1\u20134."}, {"Citation": "Ji Xuyan HZ, Li T. Effect of Shunao Jieyu decoction on intestinal flora in patients with post-stroke depression. Chin J Exp Trad Med Formulae. 2022;28:107\u2013113."}, {"Citation": "Hou S, Gao Y-E, Ma X, Lu Y, Li X, Cheng J, Wu Y, Xue P, Kang Y, Guo M. Tumor microenvironment responsive biomimetic copper peroxide nanoreactors for drug delivery and enhanced chemodynamic therapy. Chem Eng J. 2021;416:129037. doi: 10.1016/j.cej.2021.129037.", "ArticleIdList": ["10.1016/j.cej.2021.129037"]}, {"Citation": "Shao K, Zhang Y, Ding N, Huang S, Wu J, Li J, Yang C, Leng Q, Ye L, Lou J. Functionalized nanoscale micelles with brain targeting ability and intercellular microenvironment biosensitivity for anti-intracranial infection applications. Adv Healthcare Mater. 2015;4:291\u2013300. doi: 10.1002/adhm.201400214.", "ArticleIdList": ["10.1002/adhm.201400214", "25124929"]}, {"Citation": "David A. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment. Adv Drug Deliv Rev. 2017;119:120\u2013142. doi: 10.1016/j.addr.2017.05.006.", "ArticleIdList": ["10.1016/j.addr.2017.05.006", "28506743"]}, {"Citation": "gang C. construction of compound inner ear drug delivery system of traditional Chinese medicine and study on drug delivery mechanism. 2017;48:32\u201336"}, {"Citation": "Liu Chao LJ, Liu S. Study on the mechanism of regulating blood-brain barrier by aromatic resuscitation drugs and the treatment of encephalopathy. J Changchun Univ Trad Chin Med. 2016;32:874\u2013877."}, {"Citation": "Cai Weiping CY, Tang L. Effects of sodium aescinate on RhoA/ROCK pathway and blood-brain barrier permeability in rats with bacterial meningitis. China J Microecol. 2022;34:644\u2013650."}, {"Citation": "\u00d6zt\u00fcrk AA, Arpagaus C. Nano spray-dried drugs for oral administration: a review. Assay Drug Dev Technol. 2021;19:412\u2013441. doi: 10.1089/adt.2021.053.", "ArticleIdList": ["10.1089/adt.2021.053", "34550790"]}, {"Citation": "Nielsen LH, Keller SS, Boisen A. Microfabricated devices for oral drug delivery. Lab Chip. 2018;18:2348\u20132358. doi: 10.1039/C8LC00408K.", "ArticleIdList": ["10.1039/C8LC00408K", "29975383"]}, {"Citation": "Pennington CA, Park JM. Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. Am J Health Syst Pharm. 2015;72:277\u2013284. doi: 10.2146/ajhp140322.", "ArticleIdList": ["10.2146/ajhp140322", "25631834"]}, {"Citation": "Goswami T, Jasti B, Li X. Sublingual drug delivery. Crit Rev Ther Drug Carrier Syst. 2008;25:449\u2013484. doi: 10.1615/CritRevTherDrugCarrierSyst.v25.i5.20.", "ArticleIdList": ["10.1615/CritRevTherDrugCarrierSyst.v25.i5.20", "19062634"]}, {"Citation": "Usach I, Martinez R, Festini T, Peris JE. Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site. Adv Ther. 2019;36:2986\u20132996. doi: 10.1007/s12325-019-01101-6.", "ArticleIdList": ["10.1007/s12325-019-01101-6", "PMC6822791", "31587143"]}, {"Citation": "Logomasini MA, Stout RR, Marcinkoski R. Jet injection devices for the needle-free administration of compounds, vaccines, and other agents. Int J Pharm Compd. 2013;17:270\u2013280.", "ArticleIdList": ["24261141"]}, {"Citation": "Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc. 2016;91:1224\u20131230. doi: 10.1016/j.mayocp.2016.06.012.", "ArticleIdList": ["10.1016/j.mayocp.2016.06.012", "27594186"]}, {"Citation": "van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet. 1991;21:110\u2013128. doi: 10.2165/00003088-199121020-00003.", "ArticleIdList": ["10.2165/00003088-199121020-00003", "1884566"]}, {"Citation": "Lowry M. Rectal drug administration in adults: how, when, why. Nurs Times. 2016;112:12\u201314.", "ArticleIdList": ["27071237"]}, {"Citation": "Yang D, Lee JS, Choi CK, Lee HP, Cho SW, Ryu W. Microchannel system for rate-controlled, sequential, and pH-responsive drug delivery. Acta Biomater. 2018; 68:249\u2013260.", "ArticleIdList": ["29269333"]}, {"Citation": "Severino P, da Silva CF, Andrade LN, de Lima Oliveira D, Campos J, Souto EB. Alginate Nanoparticles for Drug Delivery and Targeting. Curr Pharm Des. 2019; 25:1312\u20131334.", "ArticleIdList": ["31465282"]}, {"Citation": "Tang Xiang YS. Research progress of nanostructured lipid carriers in lung targeted delivery system. China Pharm. 2023;32:1\u20135."}, {"Citation": "Jain K. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegenerative Diseases. 2007; 4:287\u2013291.", "ArticleIdList": ["17627131"]}, {"Citation": "Ipar VS, Dsouza A, Devarajan PV. Enhancing Curcumin Oral Bioavailability Through Nanoformulations. Eur J Drug Metab Pharmacokinet .2019; 44:459\u2013480.", "ArticleIdList": ["30771095"]}, {"Citation": "Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007; 59:454\u2013477.", "ArticleIdList": ["17570559"]}, {"Citation": "Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010; 75:1\u201318.", "ArticleIdList": ["19782542"]}, {"Citation": "Gu Wei WC, Liu X. Synthesis of water-soluble paliperidone prodrug and its transdermal study in vitro. Drug Eval Res. 2022;45:2008\u20132016."}, {"Citation": "Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Transl Med. 2019; 4:10143\u201310154.", "ArticleIdList": ["PMC6764803", "31572799"]}, {"Citation": "Zong-ru G. Clopidogrel, a biological prodrug fortunately discovered. Acta Pharm. 2022;57:1537\u20131540."}, {"Citation": "Jiang Yuanqi DY, Chen J. Research progress of targeted preparations of traditional Chinese medicine. Chin Herbal Med. 2021;52:1156\u20131164."}, {"Citation": "Su Hui LC. Research progress of targeted preparation in the treatment of rheumatoid arthritis. Med J. 2020;39:1672\u20131676."}, {"Citation": "Fang Lin ZP, Zhang Q. Research progress of targeted preparations of adriamycin. Zhongnan Pharm. 2018;16:1263\u20131267."}, {"Citation": "Chen Mengzhang LH. Research progress of therapeutic nucleic acid and viral vector vaccine for chronic hepatitis B. Pharm Biotechnol. 2023;30:83\u201389."}, {"Citation": "Chen Juan PL, Yang X. Analysis of global research and development situation of virus vector vaccine products. China Pharm. 2022;31:24\u201329."}, {"Citation": "Song Sankong BY, Liang J. Application progress of parallel artificial membrane osmotic model in drug permeability screening of transdermal drug delivery system. China Pharm. 2023;34:502\u2013507."}, {"Citation": "Jin Yuanyuan ZX, Chen J. Research progress of new drug delivery system in transdermal drug delivery. Jilin Trad Chin Med. 2022;42:1477\u20131480."}, {"Citation": "Xue Yaqi WZ, Liang P. Progress in molecular pharmaceutics of transdermal preparations of traditional Chinese medicine. J Nanjing Univ Trad Chin Med. 2022;38:983\u2013989."}, {"Citation": "Zhou Ziye GM, Chen P. meta-analysis of the effectiveness and safety of midazolam nasal administration in children's oral diagnosis and treatment. J Clin Stomatol. 2023;39:42\u201347."}, {"Citation": "Wang Jing CR, Ge Y. Study on the law of nasal administration in ancient Chinese medicine. West Chin Med. 2022;35:113\u2013117."}, {"Citation": "Li Juan LY, Liu Y. Anti-epileptic effect of ginsenoside Rb_1 by nasal administration on pentylenetetrazol-ignited mice. Chin J Exp Trad Med Formulae. 2022;28:65\u201374."}, {"Citation": "Zeng Yuhui HZ, Lin H. Analysis of the curative effect of pevisone in the treatment of fungal otitis externa. China J Endosc. 2022;28:56\u201362."}, {"Citation": "Yang Hong ZJ, Ren D. Safety evaluation of volatile oil from Artemisia argyi by external auditory canal in guinea pigs. J Yunnan Coll Trad Chin Med. 2020;43:11\u201315."}, {"Citation": "Hou S, Gao Y-E, Ma X, Lu Y, Li X, Cheng J, Wu Y, Xue P, Kang Y, Guo M. Tumor microenvironment responsive biomimetic copper peroxide nanoreactors for drug delivery and enhanced chemodynamic therapy. Chemical Engineering Journal. 2021; 416:129\u2013137."}, {"Citation": "Wang Yue HY, Zhu D. Application of nano-drug delivery system based on polyamide dendrimer prodrug in the treatment of malignant tumor. Zhongnan Pharm. 2021;19:1343\u20131352."}, {"Citation": "Zhang Zhigang FX, Lian Lulu. Research progress on regulating the permeability of blood-brain barrier by aromatic resuscitation drugs. 2022; 15:1510\u20131516."}, {"Citation": "Li Bonan NG, Sun T. Progress in research and application of exosomes on testicular microenvironment. Progr Biochem Biophys. 2022;49:2328\u20132341."}, {"Citation": "Jiang Jianbo SQ, Ding F. Extracellular ion microenvironment regulates sleep awakening. Chin J Clin Pharmacol Ther. 2021;26:794\u2013801."}, {"Citation": "Zhang Kai WK, Xu Y, Xu J, Xu S, Dai K, Qian J, Yang Q. Development of Hawthorn leaf total flavonoids extended-release capsules based on solid dispersion technology and study on the release mechanism of dru. Mod Chin Appl Pharm. 2017;34:378\u2013384."}, {"Citation": "Bang YU, Huang C, Liu M, Zhang H. Systematic evaluation of traditional Chinese medicine nebulized inhalation method combined with conventional western medicine treatment for acute exacerbation of chronic obstructive pulmonary disease. Chin Med Emerg. 2023;32:941\u2013946."}, {"Citation": "Baoolin L. A phase I clinical trial of clinical safety, tolerability, and pharmacokinetics of injectable and haptoglobin liposomes (HK) for the treatment of patients with advanced malignant solid tum. China Drug Clinical Trial Registration and Information Publication Platform. 2017; http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml. Accessed 21 Sept 2023.1\u20134."}, {"Citation": "Yu Z, Wang D, Qi Y, Liu J, Zhou T, Rao W, Hu K. Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy. Mater Horiz. 2023;10:1661\u20131677. doi: 10.1039/D3MH00092C.", "ArticleIdList": ["10.1039/D3MH00092C", "36880811"]}, {"Citation": "Lisa Liu GZ, Wang S, Su Z, Yu B, Ma T, Bai Z. Study on the effect of Chinese medicine acupoint application on infrared thermography and clinical efficacy and evaluation of traditional Chinese medicine in middle-aged and elderly patients with thoracic paralytic heartache. Liaoning J Chin Med. 2021;48:198\u2013201."}, {"Citation": "Tingting D. Clinical study on the treatment of chloasma with soluble microneedle patches of \"Yu Yan San\". Shandong Univ Chin Med. 2022;43:12\u201315."}, {"Citation": "WANG Feifan,SONG Yunjia,WU Wenmeng et al. Analysis of the preparation and early drug release of epimedium glycoside/TiO2 nanotube composite coating on pure titanium surface. Chinese Tissue Engineering Research.2016;20(43):6416\u20136423."}, {"Citation": "Ying L. Tolerability and pharmacokinetic clinical trial study of single, multiple dose groups, randomized, double-blind, placebo-controlled, sustained-release microspheres of Staphylococcusaureus for Injection. China Drug Clinical Trial Registration and Information Publication Platform. 2014; http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml. Accessed 21 Sept 2023, 1\u20135."}, {"Citation": "Huaqing W. A phase I study to assess the tolerance and pharmacokinetics of ursolic acid liposomes. Chinese Clinical Trial Registry. 2015; https://www.chictr.org.cn/showproj.html?proj=132682. Accessed 21 Sept 2023,1\u20136."}, {"Citation": "Jianchun D. Real world study to evaluate paclitaxel liposome/carboplatin combined with PD-1 monoclonal antibody in the first-line treatment of advanced lung squamous cell carcinoma. Chinese Clinical Trial Registry. 2022; https://www.chictr.org.cn/showproj.html?proj=132682. Accessed 21 Sept 2023,1\u20134."}, {"Citation": "Su Y. A phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetic profile of injectable paclitaxel polymeric micelles in Chinese patients with advanced malignant solid tumors. China Drug Clinical Trial Registration and Information Publication Platform. 2021;http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml. Accessed 21 Sept 2023,1\u20135."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "6"}, {"Year": "2023", "Month": "10", "Day": "13"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "27", "Hour": "0", "Minute": "43"}, {"Year": "2023", "Month": "10", "Day": "26", "Hour": "23", "Minute": "55"}, {"Year": "2023", "Month": "10", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["37884969", "PMC10604811", "10.1186/s12951-023-02159-9", "10.1186/s12951-023-02159-9"]}}], "PubmedBookArticle": []}